These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32732173)

  • 1. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA nuclear enriched abundant transcript 1 impacts cell proliferation, invasion, and migration of glioma through regulating miR-139-5p/ CDK6.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Zheng YL
    J Cell Physiol; 2019 May; 234(5):5972-5987. PubMed ID: 30515782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D; Zhu X; Siqin B; Ren C; Yi F
    Toxicol Appl Pharmacol; 2022 Jul; 447():116067. PubMed ID: 35597301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
    Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
    Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.
    Hu B; Yang XB; Yang X; Sang XT
    Aging (Albany NY); 2020 Dec; 13(2):2626-2639. PubMed ID: 33318318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of CCND1.
    Zhou J; Song G; Su M; Zhang H; Yang T; Song Z
    Environ Toxicol; 2023 Jun; 38(6):1251-1264. PubMed ID: 36947456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.
    Li X; Liu J; Liu M; Xia C; Zhao Q
    Cell Cycle; 2020 Apr; 19(7):825-836. PubMed ID: 32106756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p.
    Li S; Zhang Q; Liu W; Zhao C
    BMC Cancer; 2021 Mar; 21(1):290. PubMed ID: 33736615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
    Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
    Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J; Jia Y; Chen H; Chen W; Zhou X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
    Cheng B; Rong A; Zhou Q; Li W
    J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
    Liu Y; Geng X
    Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.